Objective: China's national hepatitis burden is high. This study aims to provide a detailed national-level description of the reported incidence of viral hepatitis in China during 2004-2016.

Design: Observational study.

Setting: Data were obtained from China's National Notifiable Disease Reporting System, and changing trends were estimated by joinpoint regression analysis.

Participants: In this system, 16 927 233 reported viral hepatitis cases occurring during 2004-2016 were identified.

Primary Outcome Measure: Incidence rates per 100 000 person-years and changing trends were calculated.

Results: There were 16 927 233 new cases of viral hepatitis reported in China from 2004 to 2016. Hepatitis B (HBV) (n=13 543 137, 80.00%) and hepatitis C (HCV) (n=1 844 882, 10.90%) accounted for >90% of the cases. The overall annual percent change (APC) in reported cases of viral hepatitis and HBV were 0.3%(95% CI -2.0 to 0.8, p=0.6) and -0.2% (95% CI -1.6 to 1.2, p=0.8), respectively, showing a stable trend. HBV rates were highest in the 20-29 year old age group and lowest in younger individuals, likely resulting from the universal HBV vaccination. The reported incidence of HCV and hepatitis E (HEV) showed increasing trends; the APCs were 14.5% (95% CI 13.1 to 15.9, p<0.05) and 4.7% (95% CI 2.8 to 6.7, p<0.05), respectively. The hepatitis A (HAV) reporting incidence decreased, and the APC was -13.1% (95% CI -15.1 to -11.0, p<0.05). There were marked differences in the reporting of hepatitis among provinces.

Conclusions: HBV continues to constitute the majority of viral hepatitis cases in China. Over the entire study period, the HBV reporting incidence was stable, the HCV and HEV incidence increased and the HAV incidence decreased. There were significant interprovincial disparities in the burden of viral hepatitis, with higher rates in economically less-developed areas. Vaccination is important for viral hepatitis prevention and control.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701656PMC
http://dx.doi.org/10.1136/bmjopen-2018-028248DOI Listing

Publication Analysis

Top Keywords

viral hepatitis
20
hepatitis
9
reported viral
8
hepatitis china
8
china 2004
8
2004 2016
8
china's national
8
reported incidence
8
changing trends
8
927 233
8

Similar Publications

Article Synopsis
  • The report updates the 1999 CDC Framework for Program Evaluation in Public Health to include new advancements and lessons learned in evaluation and public health.
  • The 2024 framework introduces a nonprescriptive tool with six steps for effective evaluation planning and implementation, while emphasizing engagement, equity, and learning from insights.
  • It serves as a guide for designing evaluations applicable to various programs, enhancing evidence-based decision-making, and improving program outcomes across different areas.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!